“Tokyo-1” Featured in NVIDIA Blog

“Tokyo-1,” the AI drug discovery consortium operated by Xeureka, was recently featured in NVIDIA blog post highlighting how Japan’s pharmaceutical industry is leveraging AI and accelerated computing to advance drug discovery.

https://blogs.nvidia.com/blog/japan-ecosystem-2026/#bionemo-rapids